Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial

BACKGROUND: Ongoing HIV-1 replication in lymphoid cells is one explanation of the persistence of HIV-1 reservoirs despite highly active antiretroviral therapy (cART). We tested the potential of cART intensification by Maraviroc plus Raltegravir to decrease proviral HIV-1 DNA levels in lymphoid cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafeuillade, Alain, Assi, Assi, Poggi, Cécile, Bresson-Cuquemelle, Caroline, Jullian, Eric, Tamalet, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197239/
https://www.ncbi.nlm.nih.gov/pubmed/25320633
http://dx.doi.org/10.1186/1742-6405-11-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197239/
https://www.ncbi.nlm.nih.gov/pubmed/25320633
http://dx.doi.org/10.1186/1742-6405-11-33

Ejemplares similares